Feasibility studies at all levels of new product, process or service development are essential to ensuring R&D return on investment. Reseva can undertake a range of feasibility assessments including techno-economic evaluations, market studies, cost of goods calculations, capital cost estimation for new plants, and technical risk/ technology readiness studies.
Reseva can also provide guidance on biochemical and chemical process technology development including selection of unit operations and optimisation of chemical processes.
Feasibility studies have been completed for over 30 products including most of the antiretrovirals (e.g. zidovudine, stavudine, abacavir and tenofovir), thymidine, microbicides, vitamin C, t-butylhydroquinone, butylated hydroxyanisole, polysaccharides, catechol, carvone and lysine.
List of relevant Reseva publications and projects:
Walwyn, D.R., Huddy, S.M. & Rybicki, E.P. 2015. Techno-Economic Analysis of Horseradish Peroxidase Production Using a Transient Expression System in Nicotiana benthamiana. Applied Biochemistry and Biotechnology, 175(2), pp 841-854.
Gordon, G., M. Bode, D. Visser, M. Lepuru, J. Zeevaart, N. Ragubeer, M. Ratsaka, D. Walwyn, and D. Brady. 2011. An Integrated Chemo-enzymatic Route for Preparation of β-Thymidine, a Key Intermediate in the Preparation of Antiretrovirals. Organic Process Research & Development, 15, pp 258-265.
Walwyn, D. 1992. A techno-economic study of the production of polysaccharide by Porphyridium aerugineum. SA Journal of Chemical Engineering. 4:1-18.